Cetirizine (Adco Cetirizine, Ceticit)
Cetirizine
Adcock ingram limited
Registration
- Applicant
- Adcock ingram limited
- Registrations
- 3
Variants
| Product | Strength and form | Registration | Status | Schedule | Leaflets |
|---|---|---|---|---|---|
| Adco cetirizine tablets EACH TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE 10,0 mg | Tablets | 36036836/5.7.1/0368 | Cancelled | Not determined | None |
| Ceticit syrup EACH 1,0 ml SYRUP CONTAINS CETIRIZINE DIHYDROCHLORIDE 1,0 mg | 1 mg/1 mLOral syrup | 36036936/5.7.1/0369Approved 20 February 2024 | Registered | Not determined | PIPIL |
| Ceticit EACH TABLET CONTAINS CETIRIZINE DIHYDROCHLORIDE 10,0 mg | 10mgFilm-coated tablets | 42082142/5.7.1/0821Approved 20 February 2024 | Registered | Not determined | PIPIL |
Regulatory status
This product is still scheduled by law even when this site could not determine which tier it falls under. The label carries the S number in a square border; ask a pharmacist if you need to know its schedule.
Listings for this ingredient that could not be applied to this product
S1: Cetirizine
Consolidated Schedules 06 July 2026, line 318
5 of 11 approved products with this ingredient carry S2 on their leaflet.
This is an informational summary of the Medicines and Related Substances Act 101 of 1965 and its 2017 General Regulations. It is not medical advice and not legal advice. Always check the medicine's label, which carries the schedule number inside a square border, or ask a pharmacist if you are unsure.
2-[2-[4-[(4-Chlorophenyl)-phenylmethyl]piperazin-1-yl]ethoxy]acetic acid
Drag to rotate. Structure from PubChem CID 2678.
SAHPRA documents
These documents are provided by SAHPRA for informational purposes. Always consult with a healthcare professional for medical advice.